Olajumoke Evangelina Owokotomo

机构：GlaxoSmithKline (Switzerland)

发表论文 11 篇 · 总被引 58 次 · h-index 3

代表论文

• The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer (2018 · BMC Cancer · 被引 20)
• Exploring the Microbiome Analysis and Visualization Landscape (2021 · Frontiers in Bioinformatics · 被引 18)
• Correlations between the metabolic profile and 18F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients (2019 · Scientific Reports · 被引 12)
• Development of Microbiome Biomarkers in Intervention Studies. (2023 · PubMed · 被引 3)
• Development of multiple microbiome biomarkers using penalized regression methods (2025 · Journal of Applied Microbiology · 被引 2)
• Modeling the positive testing rate of COVID-19 in South Africa using a semi-parametric smoother for binomial data (2023 · Frontiers in Public Health · 被引 2)